YOLFTbeta
Healthlead Public Company Limited

Healthlead Public Company Limited

HL · BK · Healthcare / Pharmaceutical Retailers

4.50THB+0.04 (+0.90%)

Price History

Full chart

Market Stats

Previous Close4.46
Open4.48
Day Range4.46 – 4.50
52-Week Range4.40 – 7.89
Volume93.60K
Market Cap1.11B
P/E (TTM)20.27
Forward P/E0.00
EPS0.22
Dividend Yield4.93%
Beta0.27
50-Day Avg4.97
200-Day Avg6.03

About

Healthlead Public Company Limited, together with its subsidiaries, engages in developing, importing, and distributing drugs, pharmaceuticals, cosmetic products, dietary supplements, medical devices, other healthcare products. It offers medicines, medical supplies and devices, as well as disinfectant and deodorizing products, masks, and sterilization products under the iCare, Pharmax, and Super Drug brands; and healthcare product innovations under PRIME, Besuto, and BOMSKIN brands. The company was incorporated in 2018 and is based in Nonthaburi, Thailand.

Company Details

  • SectorHealthcare
  • IndustryPharmaceutical Retailers
  • CEOMr. Supakorn Bhandhukanonda
  • Employees0
  • Headquarters99/4, Moo 10, Nonthaburi, Thailand, 11140, Thailand
  • Websitehttps://www.healthleadgroup.com

Leadership

  • Mr. Supakorn BhandhukanondaCEO & Director · b. 1988
  • Ms. Mataya Bhandhukanonda Pharm.D.President of Executive Board & Vice Chairman of the Board · b. 1959
  • Ms. Araya TantanasinCFO, Company Secretary & Director · b. 1971
  • Ms. Nattanan MeadtoDirector of Accounting
  • Ms. Pattarawan SiripongvilaiMarketing & Sales Promotion Director · b. 1978
  • Ms. Bussakorn AmphankaoHuman Resource Director · b. 1972
  • Ms. Wanwimol JongsuriyaphasHead of Internal Audit

Financials

Income Statement

Currency: THB2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue701.30M781.39M906.22M1.06B1.20B1.52B1.64B1.98B2.23B
Growth (%)-+11.42%+15.98%+17.42%+12.66%+26.76%+7.64%+20.88%+12.73%
Cost of Revenue584.36M643.43M724.17M831.18M922.42M1.14B1.26B1.51B1.73B
Gross Profit116.94M137.96M182.05M232.91M276.34M376.25M377.21M464.75M501.50M
Gross Margin16.67%17.66%20.09%21.89%23.05%24.76%23.06%23.51%22.50%
Operating Expense122.80M139.41M149.53M159.38M173.66M227.86M276.49M362.91M439.93M
Operating Income-5.86M-1.45M32.52M73.52M102.68M148.39M100.72M101.84M61.57M
Operating Margin-0.83%-0.19%3.59%6.91%8.57%9.77%6.16%5.15%2.76%
EBITDA-3.38M22.76M40.83M98.58M132.41M186.65M159.05M187.15M154.29M
EBITDA Margin-0.48%2.91%4.51%9.26%11.05%12.28%9.72%9.47%6.92%
Net Income-9.26M389.40K21.77M52.08M79.66M118.23M74.68M78.26M77.86M
Net Income Margin-1.32%0.05%2.40%4.89%6.65%7.78%4.57%3.96%3.49%
Interest Expense-03.79M6.99M5.34M5.73M8.98M13.61M16.59M
Interest Expense % of Total Revenue-0.00%0.42%0.66%0.45%0.38%0.55%0.69%0.74%

Balance Sheet

Currency: THB2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets277.31M242.86M296.60M398.20M1.12B1.29B1.38B1.50B1.60B
Total Liabilities191.37M156.53M188.50M273.23M252.41M346.20M414.29M493.23M630.30M
Total Equity85.94M86.33M108.09M124.97M865.89M941.99M968.05M1.01B967.60M
Cash4.47M11.25M27.43M34.85M705.01M146.35M334.81M168.67M37.43M
Total Debt126.49M91.69M56.30M142.38M118.03M167.34M224.30M296.47M318.41M
Net Debt122.02M80.44M28.88M107.53M-586.98M20.99M-110.51M127.80M280.99M

Cash Flow

Currency: THB2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-27.52M80.53M96.96M85.18M136.20M91.26M88.76M198.83M
Investing Cash Flow--13.60M-22.52M-11.66M-14.75M-624.51M177.28M-171.89M-162.38M
Financing Cash Flow--7.15M-41.84M-77.88M599.66M-70.34M-80.08M-83.01M-167.45M
Capital Expenditure09.82M23.47M14.80M14.81M120.67M82.87M78.47M32.19M
Free Cash Flow-17.70M57.06M82.17M70.37M15.53M8.39M10.28M166.64M
Dividends Paid-55.20M55.20M55.20M38.00M43.52M48.96M40.80M46.24M
FCF to OCF-64.33%70.86%84.74%82.62%11.40%9.19%11.58%83.81%
Dividend Paid to FCF-311.83%96.73%67.18%54.00%280.17%583.56%396.81%27.75%

Earnings

Report DateFeb 25, 2022May 16, 2022Aug 11, 2022Nov 14, 2022Feb 26, 2023May 14, 2023Aug 11, 2023Nov 13, 2023Feb 29, 2024Mar 31, 2024Aug 13, 2024Nov 13, 2024Feb 28, 2025May 14, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------
EPS Actual0.080.110.080.110.130.050.060.060.110.070.040.060.110.080.060.050.100.070.00
Surprise-------------------
TimingPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-market-After-hoursAfter-hoursPre-marketAfter-hours-----

Key Statistics & Ratios

Market Cap1.11B
Enterprise Value998.72M
Trailing P/E20.27
Forward P/E0.00
Price / Sales0.49
Price / Book1.27
EPS0.22
Book Value3.46
Revenue (TTM)2.26B
Gross Profit (TTM)584.58M
EBITDA137.36M
Profit Margin2.63%
Operating Margin0.78%
Return on Equity6.44%
Return on Assets3.87%
Shares Outstanding249.54M
Shares Float66.75M
Beta0.27
Dividend Yield4.93%
Dividend Rate0.22
Payout Ratio97.73%

Dividends

20261×
0.22Mar 11, 2026
20251×
0.17Mar 14, 2025
20241×
0.15Mar 13, 2024
20231×
0.18Mar 10, 2023
20221×
0.16Mar 11, 2022